[1]
Monika Wołosik, Natalia Bednarczyk, Rafał Bednarczyk, Radosław Krzysztof Binkowski, Agnieszka Kurek, Natalia Krajewska, Aleksandra Lejman, Aleksandra Mazurkiewicz, Hubert Sidor and Szymon Zysiak 2026. COBENFY (XANOMELINE-TROSPIUM CHLORIDE) AS A BREAKTHROUGH IN SCHIZOPHRENIA TREATMENT: POTENTIAL IMPACT ON PATIENT QUALITY OF LIFE AND HEALTHCARE ECONOMICS. International Journal of Innovative Technologies in Social Science. 1(49) (Jan. 2026). DOI:https://doi.org/10.31435/ijitss.1(49).2026.4695.